Abstract
In this paper we describe the purification to molecular homogeneity of the enzyme that cleaves the synthetic epidermal mitosis-inhibiting pentapeptide (pyroGlu-Glu-Asp-Ser-Gly; EPP) from swine serum. Biochemical characterisation of the enzyme shows a glycoprotein with apparent molecular mass of 200 kDa. The Km and Kcat values for EPP hydrolysis are 0.624 mM and 694 s-1, respectively. Use of proteinase inhibitors shows the enzyme's metalloendopeptidase character. Moreover, captopril and lisinopril prevent the cleavage of EPP. The N-terminal amino-acid sequence of the purified protein corresponds to the N-terminal amino-acid sequence of swine kidney angiotensin-converting enzyme, a dipeptidyl carboxypeptidase (EC 3.4.15.1).
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Amino Acid Sequence
-
Angiotensin-Converting Enzyme Inhibitors / pharmacology
-
Animals
-
Captopril / pharmacology
-
Carboxypeptidases / blood*
-
Carboxypeptidases / chemistry
-
Enzyme Inhibitors / pharmacology
-
Glycoproteins / chemistry
-
Growth Inhibitors / blood
-
Growth Inhibitors / metabolism*
-
Kinetics
-
Lisinopril / pharmacology
-
Molecular Sequence Data
-
Oligopeptides / metabolism*
-
Peptidyl-Dipeptidase A / metabolism*
-
Pyrrolidonecarboxylic Acid / analogs & derivatives
-
Substrate Specificity
-
Swine
Substances
-
Angiotensin-Converting Enzyme Inhibitors
-
Enzyme Inhibitors
-
Glycoproteins
-
Growth Inhibitors
-
Oligopeptides
-
epidermal pentapeptide
-
Captopril
-
Lisinopril
-
Carboxypeptidases
-
Peptidyl-Dipeptidase A
-
Pyrrolidonecarboxylic Acid